weaning off glp-1 GLP-1s: How to Taper Off Your How long do you have

The SURMOUNT-1 trial showed that tirzepatide, a dual GIP/GLP-1 receptor agonist, produced even greater weight loss (up to 20.9% at the highest dose) with proportional reductions in waist circumference

Oral spray, sublingual, and nasal delivery are increasingly viable alternatives for compliance and patient-preference reasons

Clean, Transparent Formulation

Advanced medical aesthetics, cosmetic & laser skin treatments

Buyer Takeaway: Both GLP-1 and GLP-1+GIP options work through appetite-regulating mechanisms with different pharmacological breadth

A few simple, consistent habits can help you stay on track and feel more confident managing your treatment